ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.21
-0.05%
US Tech 100
19,475.60
-0.53%
S&P 500
5,740.91
-0.08%
US Dollar vs CAD
1.35175
0.30%
Bitcoin
65,699.47
0.79%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aptose Biosciences Inc (APTO)

  7. Aptose Biosciences Inc (APTO) News

APTO

Aptose Biosciences (APTO)

Aptose Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:APTO
DateTimeSourceHeadlineSymbolCompany
09/06/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
09/05/20243:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
09/05/20243:15PMGlobeNewswire Inc.Aptose Announces Results from Special Meeting of ShareholdersNASDAQ:APTOAptose Biosciences Inc
08/30/20243:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
08/30/20243:30PMGlobeNewswire Inc.Aptose Receives $10 Million Through a Facility Agreement with Hanmi; Negotiating Future Collaboration Agreement with Hanmi to Jointly Develop TuspetinibNASDAQ:APTOAptose Biosciences Inc
08/15/20243:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
08/15/20243:30PMGlobeNewswire Inc.Aptose Announces Adjournment of its Special Meeting of ShareholdersNASDAQ:APTOAptose Biosciences Inc
08/08/20244:22PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
08/08/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
08/08/20244:06PMGlobeNewswire Inc.Aptose Reports Results for the Second Quarter 2024NASDAQ:APTOAptose Biosciences Inc
07/26/20243:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
07/19/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
07/19/20244:00PMGlobeNewswire Inc.Aptose Announces Receipt of Deficiency Notice from NasdaqNASDAQ:APTOAptose Biosciences Inc
07/17/202410:43AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APTOAptose Biosciences Inc
06/14/20246:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
06/03/20243:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
06/03/20249:32AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
06/03/20245:05AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:APTOAptose Biosciences Inc
05/31/20247:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
05/15/202410:47AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:APTOAptose Biosciences Inc
05/14/20244:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:APTOAptose Biosciences Inc
05/14/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
05/10/202410:35AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
05/06/20243:45PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
03/01/20244:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTOAptose Biosciences Inc
02/14/20243:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:APTOAptose Biosciences Inc
02/07/20245:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
02/07/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
02/07/20244:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
02/07/20244:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:APTOAptose Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:APTO

Your Recent History

USOTC
SFRX
Seafarer Exploration (PK)
USOTC
TPTW
TPT Global Tech (CE)
NASDAQ
RVNC
Revance Therapeutics
AMEX
FOXO
FOXO Technologies
USOTC
SINC
Sincerity Applied Materi... (PK)
USOTC
QSEP
QS Energy (PK)
USOTC
GNCP
GNCC Capital (CE)
USOTC
IBGR
Nexus Energy Services (PK)
USOTC
ZHUD
Zhuding (PK)
USOTC
NSAV
Net Savings Link (PK)
USOTC
IFUS
Impact Fusion (PK)
USOTC
TGRP
TRON (PK)
USOTC
SHMP
NaturalShrimp (QB)
USOTC
VPLM
Voip Pal Com (QB)
USOTC
AZRH
Azure (PK)
USOTC
MVNT
Movement Industries (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved